Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Crexendo Announces Rescheduled Presentation Time at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12, 2017
-
Enphase Energy (ENPH) Names Badri Kothandaraman as President and CEO
-
Reed's (REED) Appoints Jim Bass & Scott Grossman to Board
-
Dick's Sporting Goods (DKS) Reports Grand Opening of 10 New Stores in Six States
-
TG Therapeutics (TGTX) Plans Data Presentations at Joint ECTRIMS - ACTRIMS Meeting
-
Disney (DIS) Appoints Mary T Barra, General Motors (GM) CEO & Chairman, to Board
-
Hospital-wide access to virtual reality alleviates pain and anxiety for pediatric patients at Lucile Packard Children's Hospital Stanford
-
Hudson Pacific Properties (HPP) Names Andrea Wong to Board
-
Stanford Graduate School of Business Launches Two Educational Opportunities to Empower Youth and Entrepreneurs in Southern Africa
-
Navistar (NAV) Appoints Daniel Ninivaggi to Board
-
Penn Virginia Corporation (PVAC) Names John Brooks as CEO; Harry Quarls Appointed Executive Chairman
-
Workhorse Group (WKHS) Names Paul Gaitan as CFO
-
Model N (MODN) Appoints Neeraj Gokhale as CPO
-
Tableau Software (DATA) Acquires ClearGraph
-
Carvana Co. (CVNA) Announces Acquisition of Carlypso; Terms Not Disclosed
-
Johnson & Johnson (JNJ) Announces FDA Approval for IMBRUVICA in Adults with cGVHD
-
AbbVie (ABBV) Annouces FDA Approval of IMBRUVICA for Adults with cGVHD
-
Stanford Graduate School of Business Announces Inaugural Recipients of Its Stanford USA MBA Fellowship
-
Grainger (GWW) Announces Retirement Of Jim Ryan As Board Chairman
-
TG Therapeutics (TGTX) Announces SPA Agreement with FDA for Phase 3 Program of TG-1101 for Patients with Multiple Sclerosis
-
Bank of the West Classic Opens July 31, Bringing Four Grand Slam Winners to Stanford
-
Syros Pharmaceuticals (SYRS) Releases Foundational Data Supporting Ongoing Phase 2 Clinical Trial of SY-1425 for Genomically Defined AML & MDS Patients
-
Pennymac Financial Services (PFSI) Announces Ted Tozer Is Joining Its Board of Directors
-
Abeona Therapeutics (ABEO) Announces Guidance from FDA to Commence Pivotal Phase 3 for EB-101 Gene Therapy for Patients with Epidermolysis Bullosa
-
Twilio (TWLO) Names Jeff Epstein to Board of Directors
-
UPDATE: Horizon Pharma (HZNP) Presents Study Results for PROCYSBI (Cysteamine Bitartrate) Delayed-Release Capsules
-
iBeat, the Lifesaving Smartwatch, Extends Seed Round to $4.5 Million; Builds Out Executive Bench with Hires from Apple and Stanford
-
Achaogen (AKAO) Names Dr. Karen Bernstein to its Board of Directors
-
Stanford Health Care and Lucile Packard Children's Hospital Stanford re-verified as a Level 1 trauma center
-
Milestone Scientific (MLSS) Names Daniel Goldberger as CEO
-
ITUS Corporation (ITUS) Appoints Amit Kumar as New CEO
-
CHF Solutions (CHFS) Granted FDA IDE Approval for Clinical Study of Aquadex FlexFlow Aquapheresis System for Pediatric Use
-
Stanford Graduate School of Business Names Darius Teter as New Executive Director of Stanford Seed
-
Stanford Graduate School of Business Names Darius Teter as New Executive Director of Stanford Seed
-
ChromaDex (CDXC) Appoints Dr. Rudolph Tanzi, Harvard Neurology Professor to Scientific Advisory Board
-
San Francisco SEO and Social Media Expert, Jason McDonald Announces Summer, 2017, Course at Stanford
-
Torex Announces the Results of Its 2017 Meeting of Shareholders
-
Pennymac Financial Services (PFSI) Approves $50M Buyback Plan
-
OvaScience (OVAS) Names Christopher Kroeger as CEO
-
Cellular Biomedicine Group (CBMG) Names Michael A. Caligiuri MD as Chair of External Advisory Board
-
Autodesk (ADSK) Names Andrew Anagnost President and CEO
-
Audentes Therapeutics (BOLD) Appoints Jennifer Jarrett to Board of Directors
-
Tandem Diabetes (TNDM) Presents Findings from PLGS Feasibility Study and Announces Approval of IDE for Pivotal Trial
-
Syros Pharmaceuticals (SYRS) Names Srinivas Akkaraju to Board
-
Atlas Financial Holdings (AFH) Names Wally Walker to Board
-
Cypress Semiconductor (CY) Executive Chairman Ray Bingham Resigns from Board
-
Harvard Bioscience (HBIO) Names James Green as Chairman
-
Eli Lilly & Co. (LLY) Updates Data for Abemaciclib with Phase 3 MONARCH 2 Data Demonstrating Superior Progression-Free Survival in Advanced Breast Cancer at ASCO Meetings
-
Myriad Genetics (MYGN) Announces Results from 2,000 Patient Study of myRisk Hereditary Cancer Test at ASCO
-
Endologix (ELGX) Announces Positive Clinical Data from Ovation LUCY Study

